4//SEC Filing
SATO VICKI L 4
Accession 0001714899-24-000155
CIK 0001714899other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 9:13 PM ET
Size
6.7 KB
Accession
0001714899-24-000155
Insider Transaction Report
Form 4
SATO VICKI L
Director
Transactions
- Sale
Common Stock
2024-07-01$22.12/sh−2,980$65,918→ 119,356 total - Sale
Common Stock
2024-07-01$22.86/sh−100$2,286→ 119,256 total
Footnotes (3)
- [F1]The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024.
- [F2]The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $21.86 to $22.83 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F3]Includes 5,967 unvested RSUs.
Documents
Issuer
Denali Therapeutics Inc.
CIK 0001714899
Entity typeother
Related Parties
1- filerCIK 0001197020
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 9:13 PM ET
- Size
- 6.7 KB